1964
DOI: 10.1016/s0021-9258(18)91353-0
|View full text |Cite
|
Sign up to set email alerts
|

Pseudofeedback Inhibition of Purine Synthesis by 6-Mercaptopurine Ribonucleotide and Other Purine Analogues

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0
1

Year Published

1965
1965
2000
2000

Publication Types

Select...
7
2

Relationship

2
7

Authors

Journals

citations
Cited by 151 publications
(4 citation statements)
references
References 26 publications
0
3
0
1
Order By: Relevance
“…reports of nucleotide analogs that mimic natural regulatory nucleotides by activating or inhibiting regulatory enzymes. 6-Thioinosine 5 '-phosphate, 6-thioguanosine 5 '-phosphate, and 8-azaguanosine 5 '-phosphate inhibit phosphoribosyl pyrophosphate amidotransferase from pigeon liver (McCollister et al, 1964) and it has been proposed that these nucleotides are acting as analogs of the natural regulator GMP (Caskey et al, 1964).…”
Section: Discussionmentioning
confidence: 99%
“…reports of nucleotide analogs that mimic natural regulatory nucleotides by activating or inhibiting regulatory enzymes. 6-Thioinosine 5 '-phosphate, 6-thioguanosine 5 '-phosphate, and 8-azaguanosine 5 '-phosphate inhibit phosphoribosyl pyrophosphate amidotransferase from pigeon liver (McCollister et al, 1964) and it has been proposed that these nucleotides are acting as analogs of the natural regulator GMP (Caskey et al, 1964).…”
Section: Discussionmentioning
confidence: 99%
“…Purine-like inhibitors acting at the hydroxypurine site, like allopurinol, have also been designed . However, they can have the undesirable effect of interfering with other aspects of purine metabolism . Knowledge of the molecular interactions that modulate the binding to the purine site would be very helpful in the design of potent, specific inhibitors lacking secondary effects.…”
Section: Introductionmentioning
confidence: 99%
“…In a non-matching control group, transaminases fell rapidly in those patients treated with azathioprine (in two to four weeks), but the difference after three months was no longer statistically significant. In serial biopsy tests on 27 patients there were nine who had improvement, 12 tratados a lo largo de 3 a 12 meses con azatioprina (Imuran, Imurel®); la dosis inicial alcanzó 150 mg/d, la de mantenimiento 50-100 mg/d. La elevada actividad de las transaminasas séricas GOT y GPT remitió en 35 pacientes, siguió inalterada en otros 16 y siguió elevándose en S casos.…”
Section: Ergebnisseunclassified